Gilead Sciences Inc. has appointed former Bristol-Myers Squibb Co. executive Johanna Mercier to serve as chief commercial officer, effective July 1.
Foster City, Calif.-based Gilead said Mercier most recently was president and head of Bristol-Myers' large markets division, which includes the U.S, France, Germany and Japan. Mercier had been with Bristol-Myers for over 10 years, according to her LinkedIn profile.
In addition, Gilead noted that Laura Hamill, executive vice president of worldwide commercial operations, will leave the company. Hamill joined Gilead in 2018, after serving at Amgen Inc. for over 16 years.